FDC is currently trading at Rs. 259.00, up by 4.00 points or 1.57% from its previous closing of Rs. 255.00 on the BSE.
The scrip opened at Rs. 259.00 and has touched a high and low of Rs. 259.00 and Rs. 259.00 respectively.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 319.00 on 07-Mar-2018 and a 52 week low of Rs. 164.00 on 31-Aug-2017.
Last one week high and low of the scrip stood at Rs. 259.00 and Rs. 240.00 respectively. The current market cap of the company is Rs. 4,605.00 crore.
The promoters holding in the company stood at 69.07%, while Institutions and Non-Institutions held 13.63% and 17.30% respectively.
FDC’s manufacturing facility for Active Pharmaceutical Ingredients (API’s) located at Roha in state of Maharashtra, was recently inspected by US Food and Drug Administration (USFDA). It has successfully cleared the USFDA GMP inspection with ‘No observation’.
This was the 12th consecutive successful USFDA inspection of this facility. The Active Pharmaceutical Ingredients (API’s) manufactured at the above facility continues to be exported to USA.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
